Skip to main content
SpringerLink
Log in

Renal Transplantation for Diabetic Nephropathy

  • Chapter
The Kidney and Hypertension in Diabetes Mellitus

  • 241 Accesses

Abstract

Throughout the industrialized world, as reported in the United States, Japan, and western Europe, diabetes mellitus is the leading cause of end-stage renal disease (ESRD). According to the United States Renal Data System (USRDS) 1999 Report, of 79,102 patients begun on therapy for ESRD during 1997, 33,096 (44.4%) had diabetes, an incidence rate of 120 per million population (USRDS, 1999) (figure 41-1). Once begun on treatment, whether by dialysis or a kidney transplant, diabetic patients suffer a higher death rate compared to other causes of ESRD, resulting in their lower prevalence among U.S. diabetic ESRD patients (on December 31, 1997) of 33.2% (100,892 of 304,083 patients) [1]. Glomerulonephritis and hypertensive renal disease rank below diabetes in incidence of ESRD patients, substantiating Mauer and Chavers’s early recognition in 1985 that “Diabetes is the most important cause of ESRD in the Western world [2]”

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. United States Renal Data System, USRDS 1999 Annual Data Report, The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Bethesda, MD, August 1999.

    Google Scholar 

  2. Mauer SM, Chavers BM. A comparison of kidney disease in type I and type II diabetes. Adv Exp Med Biol 1985; 189: 299–303.

    PubMed  CAS  Google Scholar 

  3. National Diabetes Fact Sheet, 1998. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: National estimates and general information on diabetes in the United States. Revised edition. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 1998.

    Google Scholar 

  4. National Center for Health Statistics. Health, United States, 1998. Hyattsville, Maryland: Public Health Service. 1999.

    Google Scholar 

  5. American Diabetes Association: clinical practice recommendations 1999. Diabetes Care 1999;22 Suppl 1:S1–114.

    Google Scholar 

  6. Robertson RP, Sutherland DE, Lanz KJ. Normoglycemia and preserved insulin secretory reserve in diabetic patients 10–18 years after pancreas transplantation. Diabetes 1999;48:1737–1740.

    Article  PubMed  CAS  Google Scholar 

  7. American Diabetes Association: clinical practice recommendations 1999. Diabetes Care 1999;22 Suppl 1:S1–114.

    Google Scholar 

  8. Ghavamian, M, Gutch, C. F., Kopp, K. F., and Kolff, W. J. 1972. The sad truth about hemodialysis in diabetic nephropathy. JAMA, 222:1386–1389.

    Article  PubMed  CAS  Google Scholar 

  9. Lemmer ER, Swanepoel CR, Kahn D, van-Zyl-Smit R. Transplantation for diabetic nephropathy at Groote Schuur Hospital. S Afr med J 1993;83:88–90.

    PubMed  CAS  Google Scholar 

  10. Basadonna G, Matas AJ, Gillingham K, Sutherland DE, Payne WD, Dunn Dl, Gores PF, Gruessner RW, Arrazola I, Najarian JS. Kidney transplantation in patients with type I diabetes: 26-year experience at the University of Minnesota. Clinical Transplants 1992, 1993. Paul I. Terasaki, J.M. Cecka Eds, UCLA Tissue Typing Laboratory, Los Angeles, California, pp227-235.

    Google Scholar 

  11. Lowder GM, Perri NA, Friedman EA. 1988. Demographics, diabetes type, and degree of rehabilitation in diabetic patients on maintenance hemodialysis in Brooklyn. J Diabetic Complications 2:218–226.

    Article  CAS  Google Scholar 

  12. Nagai N. 1982. Clinical statistics of 551 patients with diabetes mellitus found before 30 years of age. J. Tokyo Worn. Med. Coll. 52:904–915.

    Google Scholar 

  13. Abourizk NN, Dunn JC. Types of diabetes according to National Diabetes. Data Group Classification. Limited applicability and need to revisit. 1990 Diabetes Care 13:1120–1123.

    Google Scholar 

  14. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183–1197.

    Google Scholar 

  15. Mogensen CE. Management of early nephropathy in diabetic patients. Annu Rev Med 1995;46:79–93.

    Article  PubMed  CAS  Google Scholar 

  16. Christensen CK, Christiansen JS, Schmitz A, Christensen T, Hermansen K, Mogensen CE. 1987. Effect of continuous subcutaneous insulin infusion on kidney function and size in Type 1 patients. A 2 year controlled study. J Diab Compl, 1: 91–95.

    CAS  Google Scholar 

  17. Mogensen CE. 1992. Angiotensin converting enzyme inhibitors and diabetic nephropathy. BMJ, 304:327–328.

    Article  PubMed  CAS  Google Scholar 

  18. Balodimus MC. 1971. Diabetic nephropathy. In:“Joslin’s Diabetes” (Eds A Marble, P White, RF Bradley, LP Krall), Lea and Febiger, Philadelphia, pp 526–56

    Google Scholar 

  19. Grenfell A, Watkins PJ. 1986. Clinical diabetic nephropathy: natural history and complications. Clin Endocrin Metab 15:783–805.

    Article  CAS  Google Scholar 

  20. Humphrey LL, Ballard DJ, Frohnert PP, Chu CP, O’Fallon WM, Palumbo PJ. 1989. Chronic renal Failure in non-insulin-dependent diabetes mellitus. Ann Intern Med, 10:788–796.

    Article  Google Scholar 

  21. Hasslacher CH, Ritz E, Wahl P, Michael C. 1989. Similar risks of nephropathy in patients with type I or type II diabetes mellitus. Nephrol Dial Transplant, 4: 859–863.

    PubMed  CAS  Google Scholar 

  22. Ritz E, Nowack D, Fliser D, Koch M, Tschope W. 1991. Type II diabetes mellitus: Is the renal risk adequately appreciated? Nephrol Dial Transplant, 6: 679–682.

    Article  PubMed  CAS  Google Scholar 

  23. Rosenbloom AL, Joe JR, Young RS, Winter WE. 1999. Emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999;22:345–354.

    Article  PubMed  CAS  Google Scholar 

  24. Balodimus MC. 1971. Diabetic nephropathy. In:“Joslin’s Diabetes” (Eds A Marble, P White, RF Bradley, LP Krall), Lea and Febiger, Philadelphia, pp 526–561.

    Google Scholar 

  25. De Jong PE, Navis G, de Zeeuw Renoprotective therapy: titration against urinary protein excretion. 1999 Lancet;354:352–353.

    Google Scholar 

  26. Locatelli F, Del Vecchio L How long can dialysis be postponed by low protein diet and ACE inhibitors? 1999 Nephrol Dial Transplant 14:1360–1364.

    Google Scholar 

  27. Neu S, Kjellstrand CM. Stopping long-term dialysis. An empirical study of withdrawal of life-supporting treatment. N Engl J Med 1986;314:14–20.

    Article  PubMed  CAS  Google Scholar 

  28. Khauli RB, Steinmuller DR, Novick AC, et al. 1986. A Critical Look at Survival of Diabetics with End-Stage Renal Disease: Transplantation Versus Dialysis Therapy. Transplantation 41: 598–602.

    Article  PubMed  CAS  Google Scholar 

  29. Sutherland DER, Morrow CE, Fryd DS, Ferguson R, Simmons RL, Najarian JS. 1982. Improved patient and primary renal allograft survival in uremic diabetic recipients. Transplantation 34:319–325.

    Article  PubMed  CAS  Google Scholar 

  30. Reltig and Levinsky ed. 1991. Institute for Medicine (U.S.) Kidney Failure and the Federal Government Access to Kidney Transplantation. Nat. Academy of Sciences p. 167-186.

    Google Scholar 

  31. Paterson AD, Dornan TL, Peacock I, Burden RP, Morgan AG, Tattersall RBI. 1987. Cause of death in diabetic patients with impaired renal function. An audit of a hospital diabetic clinic population. Lancet 1: 313–316.

    Article  PubMed  CAS  Google Scholar 

  32. Braun WE, Phillips D, Vidt DG. 1983. The Course of Coronary Artery Disease in Diabetics with and without Renal Allografts. Transplant Proc 15: 1114–1119.

    Google Scholar 

  33. Khauli RB, Steinmuller DR, Novick AC, et al. 1986. A Critical Look at Survival of Diabetics with End-Stage Renal Disease: Transplantation Versus Dialysis Therapy. Transplantation 41: 598–602.

    Article  PubMed  CAS  Google Scholar 

  34. Philipson JD, Carpenter BJ, Itzkoff J, Hakala TR, Rosenthal JT, Taylor RJ, Puschett JB.1986. Evaluation of cardiovascular risk for renal transplantation in diabetic patients. Am JMed 81:630–634.

    CAS  Google Scholar 

  35. Corry RJ, Nghiem DD, Schanbacher B, et al. 1987. Critical Analysis of Mortality and Graft Loss Following Simultaneous Renal — Pancreatic Duodenal Transplantation. Transplant Proc 19: 2305–2306.

    PubMed  CAS  Google Scholar 

  36. Gill JB, Ruddy TD, Newell JB, et al. 1987. Prognostic Importance of Thallium Uptake by the Lungs During Exercise in Coronary Artery Disease. N Engl J Med 317: 1485–1489.

    Article  Google Scholar 

  37. Fanning WJ, Henry ML, Sommer BG, et al. 1986. Lower Extremity and Renal Ischemia Following Renal Transplantation. Vascular Surg 23: 231–234.

    Article  Google Scholar 

  38. Gonzalez-Carrillo M, Moloney A, Bewick M, et al. 1982. Renal Transplantation in Diabetic Nephropathy. Br Med J 285: 1713–1716.

    Article  CAS  Google Scholar 

  39. Abendroth D, Landgraf R, Illner WD, Land W. 1990. Beneficial Effects of Pancreatic Transplantation in Insulin-Dependent Diabetes Mellitus Patients. Transplant Proc 22: 696–697.

    PubMed  CAS  Google Scholar 

  40. Sutherland DER. 1988. Who should get a Pancreas Transplant? Diabetes Care 11: 681–685.

    PubMed  CAS  Google Scholar 

  41. Osterby R, Nyberg G, Hedman L, Karlberg I, Persson H, Svalander C. 1991. Kidney transplantation in type 1 (insulin-dependent) diabetic patients. Diabetelogia, 9:668–674.

    Article  Google Scholar 

  42. Mauer SM, Goetz FC, McHugh LE, et al. 1989. Long-term Study of Normal Kidneys Transplanted into Patients with Type I Diabetes. Diabetes 38: 516–523.

    Article  PubMed  CAS  Google Scholar 

  43. Najarian JS, Kaufman DB, Fryd DS, McHugh L, Mauer SM, Ramsay RC, Kennedy WR, Navarro X, Goetz FC, Sutherland DE. 1989. Long-term survival following kidney transplantation in 100 type 1 diabetic patients. Transplantation, 1:106–113.

    Article  Google Scholar 

  44. UnitedStates Renal Data System, USRDS 1992 Annual Data Report, The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Bethesda, MD, August 1992.

    Google Scholar 

  45. Hedon E (1893) Sur la consommation du sucre ches le chien apres l’extirpation du pancreas. Arch Physiol Norm Pathol 5: 154–163.

    Google Scholar 

  46. Najarian JS, Sutherland DER, Simmons RL, Howard RJ, Kjellstrand CM, Ramsay RC, Goetz FC, Fryd DS, Sommer BG (1979) Ten year experience with renal transplantation in juvenile onset diabetes. Ann Surg 190:487–500.

    Article  PubMed  CAS  Google Scholar 

  47. Kelly WD, Lillehei RC, Merkel FK, et al. 1967. Allotransplantation of the Pancreas and Duodenum along with the Kidney in Diabetic Nephropathy. Surgery 61: 827–837.

    PubMed  CAS  Google Scholar 

  48. Lillehei RC, Ruiz JO, Acquino C, Goetz FC (1976) Transplantation of the Pancreas. Acta Endocrinol 83(Suppl 205): 303–318.

    Google Scholar 

  49. Gliedman ML, Gold M, Whittaker J, Rifkin H, Soberman R, Freed S, Tellis V, Veith FJ (1973) Clinical segmental pancreatic transplantation with ureter-pancreatic duct anastomosis for exocrine drainage. Surgery 74: 171–180.

    PubMed  CAS  Google Scholar 

  50. Groth CG, Collste H, Lundgren G, Wilczek H et al: (1982) Successful outcome of segmental human pancreatic transplantation with enteric exocrine diversion after modifications in technique. Lancet 2: 522–524.

    Article  PubMed  CAS  Google Scholar 

  51. Dubernard JM, Traeqer J, Neyra P, Touraine JL, Tranchant D, Blanc-Brunat N: (1978) A new preparation of segmental pancreatic grafts for transplantation: Trials in dogs and in man. Surgery 84: 633–640.

    PubMed  CAS  Google Scholar 

  52. DiCarlo V, Castoldi R, Cristallo M, Ferrari G, Socci C, Baldi A, Molteni B, Secchi A, Pozza G, (1998) Techniques of Pancreas Transplantation through the World: An IPITA Center Study. Transplant Proc 30: 231–241.

    Article  CAS  Google Scholar 

  53. Sugitani A, Gritsch HA, Shapiro R, Bonham, CA, Egidi CA, Corry RJ (1998) Surgical Complications in 123 Consecutive Pancreas Transplant Recipients: Comparison of Bladder and Enteric Drainage Transplant Proc 30: 293–294.

    Article  PubMed  CAS  Google Scholar 

  54. Sutherland DER, Goetz FC, Najarian JS, (1980) Living related donor segmental pancreatectomy for transplantation. Transplant Proc 12(Suppl 2) 19–25.

    PubMed  CAS  Google Scholar 

  55. Humar A, Gruessner RW, Sutherland DE, (1997) Living related donor pancreas and pancreas-kidney transplantation. Br Med Bull 53: 879–891.

    Article  PubMed  CAS  Google Scholar 

  56. Seaquist ER, Robertson RP,(1992) Effects of hemipancreatectomy on pancreatic alpha and beta cell function in healthy human donors. J. Clin Invest 89: 1761–1766.

    Article  PubMed  CAS  Google Scholar 

  57. Gruessner AC and Sutherland DER. 1998. Pancreas transplants for United States (US) and non-US cases as reported to the international pancreas transplant registry (IPTR) and to the United Network for Organ Sharing (UNOS). In:“Clinical transplants 1997”. (Ed JM Cecka and PI Terasaki), UCLA Tissue Typing Laboratory, Los Angeles, pp 45-58.

    Google Scholar 

  58. Sutherland DER, Gruessner R, Dunn D, Moudry-Munns K, Gruessner A, Najarian JS, (1994) Pancreas Transplantation from living-related donors. Transplant Proc 26: 443–445.

    PubMed  CAS  Google Scholar 

  59. Ramsay RC, Goetz FC, Sutherland DE, Mauer SM, Robison LL, Cantrill HL, Knobloch WH, Najarian JS.1988. Progression of Diabetic Retinopathy After Pancreas Transplantation for Insulin — Dependent Diabetes Mellitus. N Engl J Med 318: 208–214.

    Article  PubMed  CAS  Google Scholar 

  60. Katz H, Homan M, Velosa J, et al. 1991. Effects of Pancreas Transplantation on Postprandial Glucose Metabolism. N Engl J Med. 325: 1278–1283.

    Article  PubMed  CAS  Google Scholar 

  61. Piehlmeier W, Bullinger M, Nusser J, Konig A, Illner WD, Abendroth D, Land W, Landgraf R et al. 1992. Quality of Life in Diabetic Patients Prior to or After Pancreas Transplantation in Relation to Organ Function. Transplant Proc 24: 871–873.

    PubMed  CAS  Google Scholar 

  62. Sutherland DE. 1991. Report from the International Pancreas Transplant Registry. Diabetologia, 34(Suppl 1):S28–39.

    Article  PubMed  Google Scholar 

  63. Olausson M, Nyberg G, Norden G, Frisk B, Hedman L. 1991. Outcome of pancreas transplantations in Goteberg, Sweden 1985–1990. Diabetologia, 34(Suppl l):S1–3.

    Article  PubMed  Google Scholar 

  64. Odorico JS, Becker YT, Van der Werf W, Collins B, D’Alessandro AM, Knechtle SJ, Pirsch JD and Sollinger HW. Advances in pancreas transplantation: the University of Wisconsin experience. In Clinical Transplants 1997, Cecka and Terasaki, Eds. UCLA tissue typing laboratory, Los Angeles, California.

    Google Scholar 

  65. Sasaki TM, Gray RS, Ratner RE, Currier C, Aquino A, Barhyte DY, Light JA. 1998. Successful long-term kidney-pancreas transplants in diabetic patients with high C-peptide levels. Transplantation 65:1510–1512.

    Article  PubMed  CAS  Google Scholar 

  66. Gruessner RW, Sutherland DE, Troppmann C, Benedetti E, Hakim N, Dunn DL, Gruessner AC. The surgical risk of pancreas transplantation in the cyclosporine era: an overview. J Am Coll Surg 1997;185:128–144.

    Article  PubMed  CAS  Google Scholar 

  67. Gruessner RW. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group. Clin Transplant 1997;11:299–312.

    CAS  Google Scholar 

  68. Marshak S, Leibowitz G, Bertuzzi F, Socci C, Kaiser N, Gross DJ, Cerasi E, Melloul D. 1999. Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose. Diabetes, 48(6): 1230–1236.

    Article  PubMed  CAS  Google Scholar 

  69. Rabkin JM, Leone JP, Sutherland DE, Ahman A, Reed M, Papalois BE, Wahoff DC. 1997. Transcontinental shipping of pancreatic islets for autotransplantation after total pancreatectomy. Pancreas, 15(4):415–419.

    Article  Google Scholar 

  70. Sutherland DE. 1994 Intraperitoneal transplantation of microencapsulated canine islet allografts with short-term, low-dose cyclosporine for treatment of pancreatectomy-induced diabetes in dogs. Transplantation Proceedings.. 26(2):804.

    PubMed  Google Scholar 

  71. Tuch BE, Wright DC, Martin TE, Keogh GW, Deol HS, Simpson AM, Roach W, Pinto AN. 1999. Fetal pig endocrine cells develop when allografted into the thymus gland. Transplantation Proc, 31(1-2);670–674.

    Article  CAS  Google Scholar 

  72. Ar’Rajab A, Dawidson IJ, Harris RB, Sentementes JT Immune privilege of the testis for islet xenotransplantation (rat to mouse). Transplant Proc 1994 Dec;26(6):3446.

    Google Scholar 

  73. Gray DW. 1990 Islet isolation and transplantation techniques in the primate.. Surgery, Gynecology and Obstetrics, 170(3):225–232.

    PubMed  CAS  Google Scholar 

  74. Leow CK. Shimizu S. Gray DW. Morris PJ. 1994 Successful pancreatic islet autotransplantation to the renal subcapsule in the cynomolgus onkey.. Transplantation. 57(1):161–164.

    PubMed  CAS  Google Scholar 

  75. Stevens RB. Lokeh A. Ansite JD. Field MJ. Gores PF. Sutherland DE. 1994.Role of nitric oxide in the pathogenesis of early pancreatic islet dysfunction during rat and human intraportal islet transplantation.. Transplantation Proceedings. 26(2):692.

    PubMed  CAS  Google Scholar 

  76. Robertson GS, Dennison AR, Johnson PR et al. 1998. A review of pancreatic islet autotransplantation. Hepatogastroenterology 45:226–235.

    PubMed  CAS  Google Scholar 

  77. Sibley R, Sutherland DER, Goetz F, Michael AF. 1985. Recurrent diabetes mellitus in the pancreas iso-and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab Invest 53:132–144.

    PubMed  CAS  Google Scholar 

  78. Benedetti E, Dunn T, Massad MG, Raofi V, Bartholomew A, Gruessner RW, Brecklin C. 1999.Successful living related simultaneous pancreas-kidney transplant between identical twins. Transplantation 67(6):915–918.

    Article  PubMed  CAS  Google Scholar 

  79. Butler D. FDA warns on primate xenotransplants. Nature 1999;398:549.

    Article  PubMed  CAS  Google Scholar 

  80. Bach FH and Fineberg HV. 1998. Call for moratorium on xenotransplants. Nature 391:326. Bakris GL, Barnhill BW, Sadler R: Treatment of arterial hypertension in diabetic humans: Importance of therapeutic selection. Kidney Int 41:912-919, 1992.

    Article  PubMed  CAS  Google Scholar 

  81. Weiss RA. Xenografts and retroviruses. Science 1999;285:1221–1223.

    Article  PubMed  CAS  Google Scholar 

  82. Paradis K, Langford G, Long Z, Heneine W, Sandstrom P, Switzer WM, Chapman LE, Lockey C, Onions D, The XEN 111 Study Group, and Otto E. Search for Cross-Species Transmission of Porcine Endogenous Retrovirus in Paients Treated with Living Pig Tissue. Science 1999; 285: 1236–1241.

    Article  PubMed  CAS  Google Scholar 

  83. Lau H, Reemtsma K, Hardy MA. 1984. Prolongation of rat islet allograft survival by direct ultraviolet irradiation of the graft. Science 223:607–609.

    Article  PubMed  CAS  Google Scholar 

  84. Lewis EJ, Hunsicker LG, Bain RP, Rhode RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N ENGL J Med 1993;329:1456–1462.

    Article  PubMed  CAS  Google Scholar 

  85. Maryniak RK, Mendoza N, Clyne D, Balakrishnan K, Weiss MA. 1985. Recurrence of diabetic nodular glomerulosclerosis in a renal transplant. Transplantation 39:35–38.

    Article  PubMed  CAS  Google Scholar 

  86. Abouna G, Adnani MS, Kumar MS, Samhan SA. 1986. Fate of transplanted kidneys with diabetic nephropathy. Lancet, 1: 622–624.

    Article  PubMed  CAS  Google Scholar 

  87. Turtle KR, Bruton L, Perusek MC, Lancaster JL, Kopp DT, DeFronzo R. 1991. Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent in insulin-dependent diabetes mellitus. N Engl J Med, 324: 1626–1632.

    Article  Google Scholar 

  88. Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M. 1999. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 1998;339:69–75.

    Article  Google Scholar 

  89. Brownlee, M. Glycation and diabetic complications. Diabetes 1994; 43: 837–841.

    Google Scholar 

  90. Vlassara, H. Protein glycation in the kidney: Role in diabetes and aging. Kidney Int 1996; 49: 1795–1804.

    Article  PubMed  CAS  Google Scholar 

  91. Kato H, Hayase F, Shin DB, Oimomi M, Baba S 3-Deoxyglucosone, an intermediate product of the Maillard reaction. 1989;Prog Clin Biol Res 304:69–84.

    Google Scholar 

  92. Reddy S, Bichler J, Wells-Knecht KJ, Thorpe SR, Baynes JW Reddy S, Bichler J, Wells-Knecht KJ, Thorpe SR, Baynes JW Nε-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry 1995;34:10872–108

    Article  PubMed  CAS  Google Scholar 

  93. Friedlander MA, Witko-Sarsat V, Nguyen AT, Wu YC, Labrunte M, Verger C, Jungers P, Descamps-Latscha B The advanced glycation endproduct pentosidine and monocyte activation in uremia. Clin Nephrol 1996;45:379–382.

    PubMed  CAS  Google Scholar 

  94. Sell, DR, Monnier, VM,. Structure elucidation of a senescence cross-link from human extracellular matrix. J Biol Chem 1989;264:21597–21602.

    PubMed  CAS  Google Scholar 

  95. Niwa, T, Kaatsuzaki, T, Miyazaki S, et al. Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients. J Clin Invest 1997;99:1272–1280.

    Article  PubMed  CAS  Google Scholar 

  96. Schleicher, ED, Wagner E, Nerlich, AG.Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysiine in human tissues in diabetes and aging. J Clin Invest 1997;99:3:457–468.

    Article  PubMed  CAS  Google Scholar 

  97. Schmidt, AM, Hori, O, Chen, JX, et al. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. J Clin Invest 1995; 96: 1395–1403.

    Article  PubMed  CAS  Google Scholar 

  98. Renard C, Chappey O, Wautier MP, Nagashima M, Lundh E, Morser J, Zhao L, Schmidt AM, Scherrmann JM, Wautier JL. Recombinant advanced glycation end product receptor pharmacokinetics in normal and diabetic rats. Mol Pharmacol 1997;52:54–62.

    PubMed  CAS  Google Scholar 

  99. Koschinsky T, He CJ, Mitsuhashi T, Cucala R, Liu C, Buenting C, Heitmann K, Vlassara H. Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl Avcad Sci USA 1997;94:6474–6479.

    Article  CAS  Google Scholar 

  100. Vlassara H, Fuh H, Makita Z, Krungkrai S, Cerami A, Bucala R. Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: A model for diabetic and aging complications. Proc Natl Acad Sci U S A 1992; 89: 12043–12047.

    Article  PubMed  CAS  Google Scholar 

  101. Yang CW, Vlassara H, Peten EP, He CJ, Striker GE, Striker LJ Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease. Proc Natl Acad Sci U S A 1994; 91: 9436–9440.

    Article  PubMed  CAS  Google Scholar 

  102. Vlassara, H.Serum advanced glycosylation end products: A new class of uremic toxins? Blood Purif 1994; 12: 54–59.

    Google Scholar 

  103. Knowx, LK, Stewart, AG, Hayward, PG, Morrison, WA. Nitric oxide synthase inhibitors improve skin flap survival in the rat. Microsurgery 1994; 15: 708–711.

    Article  Google Scholar 

  104. Tilton, RG, Chang, K, Corbett, JA, Misko TP, Currie MG, Cora NS, Kaplan HJ, Williamson JR Endotoxin-induced uveitis in the rat is attenuated by inhibition of nitric oxide production. Invest Ophthalmol Vis Sci 1994; 35: 3278–3288.

    PubMed  CAS  Google Scholar 

  105. Hogan, M, Cerami, A, Bucala, R. Advanced glycosylation end products block the antiproliferative effect of nitric oxide. Role in the vascular and renal complications of diabetes mellitus. J Clin Invest 1992; 90: 1105–1110.

    Article  Google Scholar 

  106. Brownlee M. Glycosylation of proteins and microangiopathy. Hosp Pract (Off Ed) 27(Suppl 1):46–50, 1992.

    Google Scholar 

  107. Vlassara H, Fuh H, Makita Z, Krungkrai S, Cerami A, Cucala R.Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications. Proc Natl Acad Sci USA. 89:12043–12047, 1992.

    Google Scholar 

  108. Makita Z, Radoff S, Rayfield EJ, Yang Z, Skolnik E, Delaney V, Friedman EA, Cerami A, Vlassara H. 1991. Advanced glycosylation end products in patients with diabetic nephropathy. New Engl J Med 325:836–842.

    Article  PubMed  CAS  Google Scholar 

  109. Ellis EN, Good BH. Prevention of glomerular basement membrane thickening by aminoguanidine in experimental diabetes mellitus. Metabolism 40:1016–1019, 1991.

    Article  PubMed  CAS  Google Scholar 

  110. Hammes HP, Martin S, Federlin K, Geisen K, Brownlee M. Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci USA. 88:11555–11558, 1991.

    Article  PubMed  CAS  Google Scholar 

  111. Yagihashi S, Kamijo M, Baba M, Yagihashi M, Nagai K. Effect of aminoguanidine on functional and structural abnormalities in peripheral nerve of STZ-induced diabetic rats. Diabetes 41:47–52, 1992.

    Article  PubMed  CAS  Google Scholar 

  112. Friedman EA, Distant DA, Fleishhacker JF, Boyd TA, Cartwright K. Aminoguanidine prolongs survival in azotemic induced diabetic rats. Amer J Kidney Dis 1997;30:253–259.

    Article  CAS  Google Scholar 

  113. Brownlee M. 1989. Pharmacological modulation of the advanced glycosylation reaction. Prog Clin Biol Res, 304:235–248.11

    PubMed  CAS  Google Scholar 

  114. Nicholls K, Mandel TE. 1989. Advanced glycosylation end-products in experimental murine diabetic nephropathy: effect of islet isografting and of aminoguanidine. Lab Invest, 60:486–491.

    PubMed  CAS  Google Scholar 

  115. Lyons TJ, Dailie KE, Dyer DG, Dunn JA, Baynes JW. 1991. Decrease in skin collagen glycation with improved glycemic control in patients with insulin-dependent diabetes mellitus. J Clin Invest, 87:1910–1915.

    Article  PubMed  CAS  Google Scholar 

  116. Corbett JA, Tilton RG, Chang K, Hasan KS, Ido Y, Wang JL, Sweetland MA, Lancaster Jr., Williamson JR, McDaniel ML. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 1992;4:552–556.

    Article  Google Scholar 

  117. Tilton RG, Chang K, Hasan KS, Smith SR, Petrash JM, Misko TP, Moore WM, Currie MG, Corbett JA, McDaniel ML et al. Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes 42:221–232, 1993.

    Article  PubMed  CAS  Google Scholar 

  118. Sensi M, Pricci F, Andreani D, DiMario U. Advanced nonenzymatic glycation endproducts (AGE): their relevance to aging and the pathogenesis of late diabetic complications. Diabetes Res 1991; 16: 1–9.

    PubMed  CAS  Google Scholar 

  119. Edelstein D, Brownlee M. 1992. Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine. Diabetes, 41:26–29.

    Article  PubMed  CAS  Google Scholar 

  120. Eika B, Levin RM, Longhurst PA. Collagen and bladder function in streptozotocin-diabetic rats: effects of insulin and aminoguanidine. J Urol 1992; 148: 167–172.

    PubMed  CAS  Google Scholar 

  121. Yang, CW, Yu, CC, Ko, YC, Huang, CC. 1998. Aminoguanidine reduces glomerular inducible nitric oxide synthase (iNOS) and transforming growth factor-beta 1 (TGF-beta 1) mRNA expression and diminishes glomerulosclerosis in NZB/W F1 mice. Clin Exp Immunol 1998; 113:258.

    Article  PubMed  CAS  Google Scholar 

  122. Milde FK, Hart LK, Zehr PS. Pancreatic transplantation. Impact on the quality of life of diabetic renal transplant recipients. Diabetes Care 1995;18:93–95.

    CAS  Google Scholar 

  123. Østerby R, Nyberg G, Hedman L, Karlberg I, Persson H, Svalander C. 1991. Kidney transplantation in type 1 (insulin-dependent) diabetic patients. Diabetelogia, 9:668–674.

    Article  Google Scholar 

  124. Bohman SO, Wilczek H, Jaremko G, et al. 1984. Recurrence of Diabetic Nephropathy in Human Renal Allografts: Preliminary Report of a Biopsy Study. Transplant Proc 16: 649–653.

    PubMed  CAS  Google Scholar 

  125. Mauer SM, Goetz FC, McHugh LE, et al. 1989. Long-term Study of Normal Kidneys Transplanted into Patients with Type I Diabetes. Diabetes 38: 516–523.

    Article  PubMed  CAS  Google Scholar 

  126. Najarian JS, Kaufman DB, Fryd DS, McHugh L, Mauer SM, Ramsay RC, Kennedy WR, Navarro X, Goetz FC, Sutherland DE. 1989. Long-term survival following kidney transplantation in 100 type 1 diabetic patients. Transplantation, 1:106–113.

    Google Scholar 

  127. Remuzzi G, Ruggenenti P, Mauer SM. Pancreas and kidney/pancreas transplants: experimental medicine or real improvement? Lancet 1994;343:27–31.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Yale University College of Medicine, New Haven, Connecticut, USA

    Amy L. Friedman M.D. & Eli A. Friedman M.D

  2. Department of Medicine, State University of New York, Health Science Center at Brooklyn, USA

    Eli A. Friedman M.D

Authors
  1. Amy L. Friedman M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eli A. Friedman M.D
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medical Department M (Diabetes & Endocrinology), Aarhus Kommunehospital Aarhus University Hospital, Aarhus C, Denmark

    Carl Erik Mogensen

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Science+Business Media New York

About this chapter

Cite this chapter

Friedman, A.L., Friedman, E.A. (2000). Renal Transplantation for Diabetic Nephropathy. In: Mogensen, C.E. (eds) The Kidney and Hypertension in Diabetes Mellitus. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4499-9_41

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-4499-9_41

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7028-4

  • Online ISBN: 978-1-4615-4499-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation